These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combined alprazolam and neuroleptic drug in treating schizophrenia. Bacher NM; Lewis HA; Field PB Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649 [No Abstract] [Full Text] [Related]
7. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia. Pecknold JC J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. Kahn JP; Puertollano MA; Schane MD; Klein DF Am J Psychiatry; 1988 Jun; 145(6):742-4. PubMed ID: 2897166 [TBL] [Abstract][Full Text] [Related]
9. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Wolkowitz OM; Breier A; Doran A; Kelsoe J; Lucas P; Paul SM; Pickar D Arch Gen Psychiatry; 1988 Jul; 45(7):664-71. PubMed ID: 3289524 [TBL] [Abstract][Full Text] [Related]
10. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. Barbee JG; Mancuso DM; Freed CR; Todorov AA Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161 [TBL] [Abstract][Full Text] [Related]
11. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view. Boza RA; Milanes F; Starkey T; Slater V; Dominguez F J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960 [No Abstract] [Full Text] [Related]
12. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia combination therapy with neuroleptics and benzodiazepines]. Ruzikowska A Psychiatr Pol; 1996; 30(1):55-64. PubMed ID: 8722239 [TBL] [Abstract][Full Text] [Related]
14. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. Meltzer HY; Sommers AA; Luchins DJ J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856 [TBL] [Abstract][Full Text] [Related]
15. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia. Johnson DA Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242 [No Abstract] [Full Text] [Related]
16. Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Wolkowitz OM; Turetsky N; Reus VI; Hargreaves WA Psychopharmacol Bull; 1992; 28(3):291-5. PubMed ID: 1362277 [TBL] [Abstract][Full Text] [Related]
17. Clinical perspectives of some neuroleptics through development and application of their assays. Midha KK; Marder SR; Jaworski TJ; McKay G; Hubbard JW; Hawes EM; Van Putten T; Wirshing WC; Aravagiri M Ther Drug Monit; 1993 Jun; 15(3):179-89. PubMed ID: 8101398 [TBL] [Abstract][Full Text] [Related]
18. AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics. Lapierre YD; von Frenckell R Mod Probl Pharmacopsychiatry; 1983; 20():193-203. PubMed ID: 6137766 [No Abstract] [Full Text] [Related]
19. [Prolonged action neuroleptics (review of the foreign literature)]. Obukhov GA Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182 [No Abstract] [Full Text] [Related]
20. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. Breier A; Elman I; Goldstein DS Adv Pharmacol; 1998; 42():785-8. PubMed ID: 9328015 [No Abstract] [Full Text] [Related] [Next] [New Search]